Invention Grant
- Patent Title: SRM/MRM assays for cancer
-
Application No.: US15811049Application Date: 2017-11-13
-
Publication No.: US10585099B2Publication Date: 2020-03-10
- Inventor: Todd Hembrough , Fabiola Cecchi , Sarit Schwartz , Kerry Scott
- Applicant: EXPRESSION PATHOLOGY, INC.
- Applicant Address: US MD Rockville
- Assignee: EXPRESSION PATHOLOGY, INC.
- Current Assignee: EXPRESSION PATHOLOGY, INC.
- Current Assignee Address: US MD Rockville
- Agency: Harness, Dickey and Pierce, P.L.C.
- Main IPC: G01N33/53
- IPC: G01N33/53 ; G01N33/567 ; A01N1/00 ; G01N33/574 ; G01N33/68 ; C07K14/705 ; G01N30/02 ; C12Q1/37 ; H01J49/26

Abstract:
Methods are provided for quantifying specific proteins directly in biological samples that have been fixed in formalin by SRM/MRM assay. Such biological samples are chemically preserved and fixed wherein said biological sample is selected from tissues and cells treated with formaldehyde containing agents/fixatives including formalin-fixed tissue/cells, formalin-fixed/paraffin embedded (FFPE) tissue/cells, FFPE tissue blocks and cells from those blocks. A protein digest is prepared from the biological sample using, for example, the Liquid Tissue reagents and protocol and a designated protein is quantitated in the digest sample by the method of SRM/MRM mass spectrometry by quantitating in the protein sample at least one or more of the described peptides. The proteins that can be detected and/or quantitated are CD3D, B7H3, B7-2, STAT1, GBP1, GPNMB, CD27, CD3E, and CD8.
Public/Granted literature
- US20180188251A1 SRM/MRM Assays for Cancer Public/Granted day:2018-07-05
Information query
IPC分类: